Four M&A Deals in June as Activity Heats Up

Week Ending June 23rd, 2023

• Biotech: 4 Transaction (2 Follow-Ons and 2 PIPEs) totaling just under $300 Million

• Med Tech: No Current Week Transactions

2023 YTD

• 85 Biotech transaction totaling just over $11 Billion v. 2022: 60 Biotech transactions totaling just under $7 Billion

• 10 Med Tech transactions totaling just over $600 Million v. 2022: 3 Med Tech transaction just over $200 Million

Private Transactions:

• Biotech: 115 Transactions / 38 European Transactions

• Med Tech: 66 US Transactions / 25 European Transactions

In June, we have seen the following acquisitions:

• Qpex Biopharma acquired by Shionogi ($100M)

• Dice Therapeutics acquired by Eli Lilly ($2.4B)

• Chinook Therapeutics acquired by Novartis ($3.2B)

• Paratek Pharmaceuticals acquired by Gunet Point Capital, Novo Holdings ($123M)

May acquisitions:

• VectivBio acquired by Ironwood Pharmaceuticals ($1.145B)

• CTI Biopharma acquired by Sobi ($1.7B)

Surely there will be a lot more to come!